Company Overview
Snapshot
Founded in December 2014 by Yoni Epstein, OrthoSpin operated with 1–10 employees. The company raised $8 million across 3 funding rounds from 2 investors. OrthoSpin was acquired by DePuy Synthes in November 2021.
Business overview
OrthoSpin develops a smart external fixation system designed to provide real-time physician follow-up and reduce patient compliance dependency. Its core technology involves a strut powered by a lightweight motor and a control box integrated into a circular hexapod fixation frame, which automatically adjusts and lengthens struts according to prescribed treatment regimens. The company serves the orthopedic treatment market, operating within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Therapeutics.
Strategic signal
OrthoSpin's acquisition by DePuy Synthes in November 2021 signals a strategic validation of its robotic external fixation technology within the orthopedic market. This exit demonstrates the potential for innovative digital health solutions to be integrated into larger medical device portfolios, indicating a trend towards advanced automation and data-driven approaches in surgical and post-operative care.
Company Intelligence Q&A
- When was OrthoSpin acquired?
- OrthoSpin was acquired by DePuy Synthes in November 2021.
- What was a key regulatory milestone for OrthoSpin's technology?
- In September 2019, OrthoSpin received regulatory clearance from the FDA for its smart robotic external fixation system for orthopedic treatment. In January 2021, the company received FDA regulatory clearance for its second-generation robotic, digitally enabled external fixation system, the OrthoSpin G2.
- Which investors participated in OrthoSpin's Series B financing round?
- In March 2020, OrthoSpin raised up to $5 million in Series B financing, with participation from Johnson & Johnson Innovation.
- What is the primary function of OrthoSpin's robotic system?
- OrthoSpin's system automatically and continuously adjusts and lengthens the struts of an external fixation frame according to a prescribed treatment regimen, without requiring patient involvement, allowing physicians to monitor progress and modify treatment schedules.
- What was the total capital raised by OrthoSpin?
- OrthoSpin raised a total of $8 million across 3 funding rounds.